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of phototherapy protocols for reduction 
of oxidative stress in partially transected spinal 
cord slices undergoing secondary degeneration
Bethany Eve Ashworth1,2, Emma Stephens1,2, Carole A. Bartlett1, Stylianos Serghiou3, Marcus K. Giacci1, 
Anna Williams3, Nathan S. Hart1,4 and Melinda Fitzgerald1*
Abstract 
Background: Red/near-infrared light therapy (R/NIR-LT) has been developed as a treatment for a range of conditions, 
including injury to the central nervous system (CNS). However, clinical trials have reported variable or sub-optimal 
outcomes, possibly because there are few optimized treatment protocols for the different target tissues. Moreover, 
the low absolute, and wavelength dependent, transmission of light by tissues overlying the target site make accurate 
dosing problematic.
Results: In order to optimize light therapy treatment parameters, we adapted a mouse spinal cord organotypic 
culture model to the rat, and characterized myelination and oxidative stress following a partial transection injury. The 
ex vivo model allows a more accurate assessment of the relative effect of different illumination wavelengths (adjusted 
for equal quantal intensity) on the target tissue. Using this model, we assessed oxidative stress following treatment 
with four different wavelengths of light: 450 nm (blue); 510 nm (green); 660 nm (red) or 860 nm (infrared) at three 
different intensities: 1.93 × 1016 (low); 3.85 × 1016 (intermediate) and 7.70 × 1016 (high) photons/cm2/s. We demon-
strate that the most effective of the tested wavelengths to reduce immunoreactivity of the oxidative stress indicator 
3-nitrotyrosine (3NT) was 660 nm. 860 nm also provided beneficial effects at all tested intensities, significantly reduc-
ing oxidative stress levels relative to control (p ≤ 0.05).
Conclusions: Our results indicate that R/NIR-LT is an effective antioxidant therapy, and indicate that effective wave-
lengths and ranges of intensities of treatment can be adapted for a variety of CNS injuries and conditions, depending 
upon the transmission properties of the tissue to be treated.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Neurotrauma encompasses spinal cord injury (SCI) and 
traumatic brain injury (TBI) and can involve damage to 
both grey and white matter of the CNS [1]. Secondary 
degeneration is a hallmark of neurotrauma, with spread-
ing damage contributing to deteriorating structure and 
function [2]. Oxidative stress contributes to secondary 
degeneration [3] and occurs when excess reactive oxygen 
species (ROS) and/or reactive nitrogen species (RNS) 
overwhelm the endogenous antioxidant ability of the 
biological system [4]. While reactive species are essential 
for a range of normal cellular processes, excess leads to 
oxidative and nitrosative disruptions including protein 
nitration, DNA oxidation and lipid peroxidation [5–7], 
resulting in compromised oxidative metabolism, ATP 
depletion, necrosis, and dysregulated apoptosis [8]. If 
the excess production of reactive species can be limited, 
oxidative damage to DNA, lipids and proteins may be 
reduced and functional outcomes improved [9].
Open Access
BMC Neuroscience
*Correspondence:  lindy.fitzgerald@uwa.edu.au 
1 Experimental and Regenerative Neurosciences, School of Animal 
Biology, The University of Western Australia, Crawley, WA, Australia
Full list of author information is available at the end of the article
Page 2 of 12Ashworth et al. BMC Neurosci  (2016) 17:21 
Red/near-infrared light therapy (R/NIR-LT), also 
known as photobiomodulation or phototherapy, is the 
therapeutic use of electromagnetic radiation at wave-
lengths characterized by relatively low energy densities 
in the red/near-infrared spectrum (600–1000  nm) [10]. 
R/NR-LT has been shown to have therapeutic effects in 
a range of CNS-specific injuries, resulting in improved 
functional recovery in cases of CNS injury [11], reti-
nal degeneration [12, 13], stroke [14] and SCI [15] in rat 
models.
A proposed mechanism underlying R/NIR-LT therapy 
at the cellular level involves the activation of cytochrome 
c oxidase (COX) [14]. COX is complex IV of the mito-
chondrial respiratory chain and is considered to be one of 
the primary photoacceptors of visible and NIR light [16–
18]. When COX absorbs photons at specific wavelengths 
(600–1000  nm), it undergoes a conformational change, 
altering its redox state, increasing its activity resulting in 
increased levels of ATP [19], and improved mitochon-
drial function [14]. Irradiation with 670  nm light has 
been demonstrated to increase COX activity and reduce 
oxidative stress in an in vivo model of secondary degen-
eration [20]; these effects consistent with improvements 
in oxidative metabolism. Additional proposed mecha-
nisms of action for R/NIR-LT include reduced inflamma-
tion and release of nitric oxide from COX [14, 21, 22].
Evidence to date indicates that R/NIR-LT is an effec-
tive and safe antioxidant therapy in a range of preclinical 
models as well as in clinical settings [20]. However, the 
NEST-3 clinical trial for stroke, delivering 630/830  nm 
light using transcranial laser therapy, failed an interim 
futility analysis [23], perhaps owing to the failure to 
implement an effective, optimized treatment protocol. It 
is difficult to identify effective treatment parameters for 
clinical trials of R/NIR-LT given the large range of wave-
lengths, intensities, pulse structure treatment durations, 
treatment intervals and delivery methods that have been 
employed to date in pre-clinical studies and which alter 
actual dose delivered [22, 24, 25]. In particular, varying 
degrees of penetrance of light, dependent on wavelength 
can confound attempts to optimise treatment param-
eters and dissect out potential mechanisms of positive 
effects. Pre-clinical in vivo data to date indicate that 670 
and 810–830 nm light are effective wavelengths [11, 26]. 
However, it is not yet clear whether efficacy is related 
to increased penetrance and thereby increased delivery 
of photons regardless of their delivery wavelength, or to 
specific effects of light at particular wavelengths. As such, 
light at short wavelengths may be even more effective 
than R/NIR wavelengths, if problems of penetration can 
be overcome.
Furthermore, effective parameters in one model do not 
necessarily apply to other models: a comparative study of 
R/NIR-LT efficacy in four CNS injury models in rat (par-
tial optic nerve transection, light-induced retinal degen-
eration, TBI and SCI) indicated that it is necessary to 
optimize parameters individually for each type of CNS 
injury [26], perhaps due to differing penetrance of the 
light therapy. Therefore, to optimise treatment parame-
ters of R/NIR-LT, a single, clinically relevant injury model 
where light can readily penetrate may assist.
Here, we adapt a well-established mouse organotypic 
spinal cord slice culture model which features the devel-
opment of myelinated axons by 7 days in vitro (DIV) [27, 
28] to rat, characterise the features of the culture system 
following partial transection injury and use it to deter-
mine the wavelengths and intensities of light therapy that 
can reduce an indicator of oxidative stress. A rat model 
was used in order to allow direct comparison to in vivo 
outcomes [26] in the same species. A model featuring 
three dimensional tissue architecture was desired as early 
attempts to optimise R/NIR-LT following excitotoxic 
insult to dissociated rat CNS cultures were unsuccessful 
[29]. Higher wavelengths of light are known to penetrate 
tissue more effectively due to the balance of increased 
absorption and reduced scattering [16, 30]. However, if 
it is merely delivery of photons that provides beneficial 
effects, shorter wavelengths may be effective in the cell 
culture context where penetrance through overlying tis-
sue is not required. We therefore assess a range of wave-
lengths from 450 to 860  nm at low, medium and high 
intensities, where the medium intensity for each wave-
length delivers an equivalent number of photons as that 
delivered by the popular VET75 LED array (Quantum 
Devices).
Results
Characterisation of injured spinal cord slice cultures 
from neonatal rat
Spinal cord slices were prepared from postnatal day (P) 
0–1 day old Piebald Virol Glaxo (PVG) rat pups. In P0–1 
pups the uninjured spinal cord slice cultures contained 
cells that were myelin basic protein (MBP) immunopo-
sitive but had no myelinated axons at 4 DIV (Fig.  1A); 
some axons were myelinated by 7 DIV (Fig. 1B). Immu-
nostained spinal cord sections collected from PVG rat 
pups similarly showed no myelinated axons in the unin-
jured spinal cord (Fig.  1C) or brain stem (Fig.  1D) at 
P0–1; or of P2 pups (not shown). Myelinated axons were, 
however, apparent in spinal cord sections at P5 (Fig. 1E), 
indicating that the development of myelination in neo-
natal rat in vitro parallels events in vivo. It is important 
to note that the myelination of axons in the uninjured 
rat spinal cord slice cultures was variable and that mye-
lination was not always apparent. Electron microscopy 
revealed that myelin was spirally wrapped around some 
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axons, but compaction of myelin was not always com-
plete (Fig.  1F–H). Myelination was most consistent in 
cultures derived from P0–1 rat pups and this age of pup 
was chosen for further analyses.
Spinal cord slice cultures from P0–1 rat pups were 
subjected to a cut injury after 7 DIV. Approximately 
half of the width of the slice was transected with a scal-
pel, resulting in transection of axons within the slice, as 
ascertained by subsequent immunohistochemical analy-
ses. At 1  day following injury, myelinated axons were 
observed less frequently than in uninjured control slices; 
myelin was often decompacted (Fig. 1I) and aggregates of 
myelin debris were present (Fig. 1J). Cut injury resulted 
in increased immunoreactivity of a range of indicators of 
oxidative stress in the slice cultures 24 h following insult, 
both adjacent to the cut area and more distally (Fig. 1K–
R). 8-hydroxyguanosine (8OHDG) immunoreactivity, 
indicative of oxidative damage to DNA was increased in 
cell bodies, and as expected, was not co-localised with 
MBP (Fig.  1K, O); the area immediately adjacent to the 
cut injury is shown (Fig. 1O). Note that immunoreactiv-
ity of MBP was not clearly aligned along axons and in 
Fig. 1 Characterisation of spinal cord slice cultures from neonatal PVG rat. Myelinated axons, indicated by β-III tubulin (green) and MBP (red) 
colocalisation, were not apparent in spinal cord slice cultures from P0–1 rat pups at 4 DIV (A) but were present at 7 DIV (B), scale = 50 µm for A, 
B. Immunohistochemical assessment of perfusion fixed spinal cord (C) and brain stem (D) from P0–1 rat pups showed no evidence of myelinated 
axons; myelinated axons were observed in spinal cord from P5 pups (E), scale = 50 µm for C–E. Electron microscopy of 7 DIV slice cultures revealed 
the presence of both relatively compact (F, G) and some decompacted myelin sheaths (H) in uncut slice cultures; cut injury 24 h previously resulted 
in increasingly decompacted myelin (I) and aggregates of myelin debris (J), scale = 1 µm. Immunoreactivity of 8OHdG (K) increased following cut 
injury (O), as did immunoreactivity of HNE (L, P), 3-NT (M, Q) and MnSOD (N, R). Immunoreactivity of all oxidative stress indicators is shown in red, 
together with MBP immunoreactivity (green) and Hoechst nuclear stain (blue); representative images adjacent to the cut injury are shown. Note 
that multiple colour immunofluorescence was employed and as such, 8OHDG and HNE images show the same field of view, as do 3NT and MnSOD 
images, scale = 50 µm
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places was reminiscent of myelin debris (Fig. 1K–R). As 
noted above, myelin debris was also observed by electron 
microscopy in cut injured cultures (Fig. 1I, J). 4-Hydrox-
ynonenal (HNE) immunoreactivity, indicative of lipid 
peroxidation, was increased and co-localised with MBP 
immunoreactivity (Fig. 1L, P), as expected given the high 
lipid content of myelin. Increased immunoreactivity of 
3-nitrotyrosine (3NT), indicative of protein nitration by 
oxidative species, serves as a marker for oxidative/nitro-
sative stress in a range of cell types including myelinat-
ing oligodendrocytes [3]. Immunoreactivity of 3-NT was 
widespread in the tissue section and immunointensity 
was slightly increased following cut injury; staining was 
not apparent in MBP positive areas after injury (Fig. 1M, 
Q). Similarly, immunoreactivity of manganese superox-
ide dismutase (MnSOD), an antioxidant enzyme which 
converts superoxide to hydrogen peroxide, was slightly 
increased following injury and seldom co-localised with 
MBP immunoreactivity, particularly following cut injury 
(Fig. 1N, R).
Additional immunohistochemical analyses were con-
ducted to ascertain whether 3NT colocalised with other 
cell types within the organotypic spinal cord slice cul-
tures. 3NT immunoreactivity was broadly expressed 
throughout the spinal cord slice cultures (Fig.  2A, D), 
with some colocalisation with NG2+/Olig2+ oligoden-
drocyte precursor cells (Fig. 2A–C, g arrows). 3NT occa-
sionally colocalised with IBA1+ microglia and ED1+ 
microglia/macrophages (Fig.  2D–F, h arrows); a control 
image where the primary antibody was omitted is pro-
vided (I). 3NT immunoreactivity was not different when 
comparing areas immediately adjacent to the cut injury, 
to areas more distal (Fig. 2J, K). The data indicate that the 
spread of oxidative/nitrosative stress occurred relatively 
rapidly, such that damage was uniformly distributed 
by 24 h after the injury. Given that the spinal cord slice 
cultures are approximately 4 mm in length, 3NT immu-
noreactivity spread more than 1.5 mm in 24 h of culture 
(L). While the size of spinal cord lesions in vivo is highly 
dependent upon the nature and severity of the injury, our 
data indicate the potential for significant spread of oxida-
tive/nitrosative damage.
As a comparison, spinal cord slice cultures were pre-
pared from P0–1 mouse pups, cultured for 10 DIV and 
then subjected to cut injury. Myelinated axons were 
clearly apparent in uninjured cultures (Fig. 3A, B). While 
lengths of MBP positive myelin were present 1 day after 
cut injury, myelin debris was apparent (Fig.  3E, F). By 
7  days after the cut injury, some MBP immunoreactiv-
ity colocalised with neurofilament positive axons in the 
uncut section, but cut axons present in the lower half of 
the image were unmyelinated (Fig. 3I–L). MnSOD immu-
noreactivity was increased, particularly adjacent to the 
cut site (Fig. 3C, G), indicating oxidative stress that may 
be contributing to demyelination in the area with tran-
sected axons and reduced myelination. Despite some 
demyelination in the cut injured mouse slice cultures, 
it is apparent that myelination was more robust in the 
mouse slice cultures than in those from rat.
Light treatment reduced an indicator of oxidative stress
We used the partially transected rat in vitro spinal cord 
slice culture model system to compare effects of treat-
ment with a range of wavelengths and intensities of light 
on oxidative stress, in tissue vulnerable to secondary 
degeneration. The slice cultures were injured at 7 DIV 
and tissue was assessed 24  h after cut injury (8DIV), 
immediately following two, 30 min light or control treat-
ments 24  h apart. Indicators of oxidative stress exam-
ined were 3NT, HNE and 8OHDG. In 450  nm treated 
spinal cord slices we detected a significant decrease in 
the area of 3NT immunoreactivity above a set threshold 
at the intermediate and high intensities relative to con-
trol (p  <  0.05) (Fig.  4A, E–H), suggesting dose depend-
ence at this wavelength. Immunoreactivity of 510  nm 
treated slices was significantly reduced at both low and 
high intensities of light compared to control (p  <  0.05) 
(Fig.  4B, E, I–K). In contrast, 660  nm light significantly 
reduced 3NT immunoreactivity consistently at all three 
tested intensities (p ≤ 0.05) (Fig. 4C, E, L–N). Similarly, 
860 nm light significantly reduced 3-NT immunoreactiv-
ity at all three intensities compared to control (p ≤ 0.05) 
(Fig. 4D, E, O–Q), albeit to a lesser extent than 660 nm 
light and with a trend to a biphasic effect. Note that there 
were no statistically significant differences between the 
varying treatment intensities for 860 nm, or 660 nm light 
(p > 0.05). Specificity of the 3-NT antibody was demon-
strated using established procedures [31], with increased 
3-NT immunoreactivity in the cell culture supernatant 
of rat pheochromocytoma (PC12) neural like cells fol-
lowing treatment with SIN-1 (morpholinosydnonimine), 
a peroxynitrate generator [32], relative to untreated 
control (Fig.  5a). The effects of the full range of wave-
lengths and intensities on immunoreactivity of 8OHDG 
and HNE were assessed following cut injury in the slice 
cultures. There were no significant effects of any of the 
wavelengths and intensities of light on 8OHDG immu-
noreactivity, when considering both the area above a set 
threshold of intensity or the mean fluorescence intensity 
of the image (Fig. 5b, mean fluorescence intensity shown). 
Similar results were observed for HNE (not shown). 
Taken together our data indicate differential effects of R/
NIR-LT on oxidative damage, with beneficial effects on 
oxidative/nitrosative damage to protein, but not damage 
to DNA or lipid. A summary table of immunohistochem-
ical outcomes of the study is provided in Table 1.  
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Discussion
R/NIR-LT is a prospective antioxidant therapy for pre-
serving function following CNS injury. The treatment 
is comparably cheap, non-invasive and easy to admin-
ister when using LED arrays, and has shown promise 
in numerous pre-clinical models of CNS injury and for 
some indications in clinical trials for stroke [20, 24]. 
However, lack of optimization using comparative stud-
ies has probably contributed to the failure of widespread 
clinical use of R/NIR-LT [24], and there is a need for a 
standardized, consensus treatment protocol. In this 
study, we have firstly developed and characterised an 
in vitro rat model of CNS injury suitable for optimizing 
treatment strategies for neurotrauma. Secondly we have 
used the model to compare a range of wavelengths and 
intensities for efficacy at reducing oxidative stress, in 
an effort to provide data useful for optimisation of light 
therapy, with the added advantage of a reduction in ani-
mal numbers required. The intensities of light delivered 
were designed to encompass those shown to be effective 
in vivo once penetrance of light has been accounted for 
[39] and were standardised for the number of photons 
that reached the surface of the cultures for each wave-
length utilised. As such, outcomes between wavelengths 
are directly comparable. Our data suggest 660  nm light 
to be the most promising wavelength of those tested for 
Fig. 2 Representative images of 3NT immunoreactivity (A, D), colocalised with some NG2/Olig2 + ve cells (B, arrow) with overlay (C), and some 
ED1/IBA1− +ve cells (E, arrow) with overlay (F). Higher magnification images of NG2/Olig2+ (G) and IBA+ (H) cells are provided, together with a 
control image omitting the 3NT primary antibody (I). 3NT immunoreactivity was approximately equivalent both adjacent to the cut injury (J) and 
more distally (K); 3NT (red), β-III tubulin (green), Hoechst nuclear stain (blue). Scale = 50 µm for images A–F, J, K; scale = 10 µm for G–I. A repre-
sentative image of a spinal cord slice with cut injury, stained with Hoechst nuclear stain (L); boxed areas indicate analysis sites close and distal from 
the injury (indicated by an arrow), scale = 200 µm
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reducing oxidative stress, performing consistently and 
effectively across all three intensity settings.
When light interacts with biological tissue, photons are 
either absorbed by cellular constituents or scattered [33], 
with optimal penetration occurring within an “optical 
window” [34]. Penetration is dependent on absorption 
and scattering [33], both of which are greater at shorter, 
blue/green wavelengths [35]. However, in the current 
in vitro study, penetrance of the different wavelengths is 
likely to be relatively uniform and the effects of equiva-
lent numbers of photons of different wavelengths were 
directly assessed. Different wavelengths of light have been 
shown to have different effects upon photoacceptors. For 
example, wavelength bands of 330, 404–420, 680 and 
825 nm [36, 37] have been shown to result in oxidation 
of COX, and distinct wavelength bands of 450, 620 and 
760 nm reduce COX [36]. Our observation of increased 
COX activity in  vivo following 670  nm treatment [38], 
indicate that oxidation of COX by red light increases the 
activity of the enzyme, at least associated with, and per-
haps mediating the therapeutic effect. The results of the 
current study demonstrating that 660  nm was the most 
effective of the tested wavelengths at reducing oxidative 
stress support these findings and indicate that oxidation 
of COX may mediate beneficial therapeutic effects.
The other tested wavelengths were outside the opti-
mal wavelengths for COX oxidation, and in the case of 
450  nm were likely to lead to reduction of the enzyme, 
perhaps accounting for the limited anti-oxidant efficacy. 
Nevertheless, the highest intensity of light tested in the 
current study still reduced 3NT immunoreactivity at all 
four tested wavelengths. Absorption of sufficient energy 
Fig. 3 The effects of cut injury on spinal cord slice cultures from neonatal mouse. Spinal cord slice cultures were cultured for 10 DIV, and either not 
cut (A–D), or subjected to cut injury (E–H). Immunohistochemical analysis of NFH (red), MBP (green) and MnSOD (blue) with overlay in uncut and 
cut cultures are shown at 11 DIV (A–H), scale = 10 µm. Immunohistochemical analysis of NFH (red), MBP (green) with overlay (I–K) and overlay with 
Hoechst (L) in cut cultures are shown at 17 DIV (I–L), scale = 20 µm
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by COX to enable conformational change may have 
resulted in release of nitric oxide from COX, [14] thereby 
leading to beneficial effects of wavelengths of light that 
reduce COX. An alternative mechanism may involve 
the flavoprotein NADH dehydrogenase (NADH-D), 
which has been suggested as a photoacceptor involved 
in blue light therapy [39]. Its action spectra peak at 
448 nm [40, 17] corresponds to the blue wavelength set-
ting used in this study (450 nm). Although activation of 
NADH-D [39, 41] may promote electron drive through 
the electron transport chain, this therapeutic effect may 
be overwhelmed by the detrimental accumulation of 
superoxide production, perhaps explaining why blue light 
has produced results reflective of lower efficacy in the 
current study. It is interesting to note that of the oxida-
tive stress measures assessed, light therapy only resulted 
in decreases in 3NT immunoreactivity, indicating that 
oxidative/nitrosative damage to proteins may be limited 
Fig. 4 3-NT immunoreactivity of spinal cord slice cultures following treatment with light of varying wavelengths and intensities. A–D Quanti-
fication of the area of 3-NT immunoreactivity above a set threshold in spinal cord slice cultures treated with 450, 510, 660 or 860 nm light. Low 
(1.93 × 1016), intermediate (3.85 × 1016), or high (7.70 × 1016) (photons/cm2/s) intensities were delivered. Significant differences from control for 
each intensity of light delivered are indicated by *(p ≤ 0.05). E–Q Representative images are provided for each treatment intensity and wavelength, 
imaged immediately adjacent to the cut: 3-nitrotyrosine immunoreactivity (3NT) is red, together with β-III tubulin immunoreactivity to identify 
axons (green) and Hoechst nuclear stain (blue) for control (E), 450 nm treated (F–H), 510 nm treated (I–K), 660 nm treated (l–N) or 860 nm treated 
(O–Q) cultures. Scale = 50 µm for all images. Each experiment was conducted three times and data from a single experiment with 8 replicates per 
group are shown
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by the mechanisms described above, whereas damage 
to DNA and lipid oxidation are not. Assessment of anti-
inflammatory effects of the various wavelengths in the 
current model would also be interesting to address.
Measures of oxidative damage in the current study 
rely upon the specificity of the commercial antibodies 
employed. It is challenging to confirm specific immu-
nostaining of oxidative or nitrosative damage: for 
example, increased nitrotyrosine immunoreactivity in 
tissue reflects nitration of tyrosines in a large range of 
proteins in response to oxidative and nitrosative stress. 
As such, Western analysis of binding of the antibody 
will result in a large number of bands and commercial 
descriptions of these antibodies do not show Western 
blots. Nevertheless, our observation of increased 3-nitro-
tyrosine immunoreactivity in the supernatant of cells 
treated with the peroxynitrate generator SIN-1 [31] indi-
cates that changes in immunoreactivity occur in response 
to reactive nitrogen species.
Complete transection of the spinal cord, although 
reflective of complete SCI in patients [42], is rarely seen 
in the clinic [43, 44] and partial transection models are 
more reflective of clinical SCI. Furthermore, partial tran-
section models are valuable for assessing axonal regen-
eration as an additional measure in SCI [45, 46], and are 
increasingly used to assess the effects of combinatorial 
therapies on axonal regeneration post-injury [47]. Our 
data suggest 660  nm as an effective wavelength setting 
Fig. 5 3NT immunoreactivity in SIN-1 treated PC12 cells and 8OHDG immunoreactivity of spinal cord slice cultures following treatment with light 
of varying wavelengths and intensities. A PC12 cell supernatant 3NT immunoreactivity following treatment with 1, 3 or 10 mM SIN-1 relative to 
untreated control cells. B Quantification of the area of 8OHDG immunoreactivity above a set threshold in spinal cord slice cultures treated with 450, 
510, 660 or 860 nm light. Low (1.93 × 1016), intermediate (3.85 × 1016), or high (7.70 × 1016) (photons/cm2/s) intensities were delivered. There were 
no significant differences between control and treatment groups. The experiment was conducted three times and data from a single experiment 
with 8 replicates per group are shown
Table 1 Summary of immunohistochemical outcomes
+ Is increased immunoreactivity, ++ is strongly increased immunoreactivity, − 












8OHDG ++ − ND −
HNE + + ND −
3NT + − + ↓
MnSOD + − ND ND
Page 9 of 12Ashworth et al. BMC Neurosci  (2016) 17:21 
for light therapy. However in order to ensure delivery of 
sufficient intensity of light at this wavelength to injured 
tissue in  vivo, it is necessary to assess transmission of 
the light through the overlying tissue. Calculated and 
measured assessments of penetrance of irradiation to 
the spinal cord range from 6 to 11.3 % depending upon 
wavelength [11, 24, 26]. Together with data from the cur-
rent study, these values can be used to calculate likely 
effective dosages of R/NIR-LT to SCI. The lowest effec-
tive intensity of 660 nm light tested here was 1.93 × 1016 
photons/cm2/s. We have measured that the VET75 LED 
array delivers 5.3  ×  1016 photons/cm2/s to the surface 
of the skin when held at 3 cm above the skin [26]. Given 
6.6  % penetrance, we calculate that only approximately 
0.35  ×  1016 photons/cm2/s penetrate to the SCI, per-
haps explaining our observed lack of effect of R/NIR-LT 
following SCI in vivo [26]. The nature of individual CNS 
injuries may impact upon efficacy of R/NIR-LT, with dif-
fering disease pathologies likely differentially modulated 
by altered photoacceptor activity. For example, increased 
glial scarring and immune cell infiltration in SCI may 
overwhelm positive effects of R/NIR-LT on oxidative 
stress. Nevertheless, it is apparent that transmission of 
R/NIR-LT must be carefully considered when designing 
effective R/NIR-LT treatment protocols for CNS injuries.
Conclusions
Our comparative assessment has resulted in the identi-
fication of effective protocols of R/NIR-LT that can be 
adapted to individual CNS injuries, bearing in mind the 
transmission properties of the injured and overlying tis-
sue. We have demonstrated that 660 nm red light is the 
most effective of the tested wavelengths at reducing oxi-
dative stress, likely due to oxidation of COX. R/NIR-LT 
at 860 nm also significantly reduced oxidative stress at all 
tested intensities. We conclude that although R/NIR-LT 
appears to be a relatively simple therapy, the choice of 
dose regime and wavelength utilised needs as much care 
and attention as designing drug dosing protocols.
Methods
All procedures involving animals were approved by the 
University of Western Australia Animal Ethics Commit-
tee, Approval number RA3/100/673, or the UK Home 
Office project licence number 60/4524 and adhered to 
the National Health and Medical Research Australian 
Code of Practice for the care and use of animals for sci-
entific purposes. Neonatal PVG rat pups (P0–P5), sex 
not specified, were procured from the Animal Resources 
Centre (Murdoch, Western Australia). The mother and 
pups were housed under standard conditions including 
12 h light/dark cycles and ad libitum access to chow and 
water.
Spinal cord collection and culture
Rat or mouse pups at P0–1 days old (n = 6/experiment) 
were euthanized using pentobarbital (Virbac, Australia 
Pty. Ltd., NSW, Australia), administered intraperito-
neally at a dose of 800–1000  mg/kg (~0.02 to 0.03  ml) 
as per standard best practice. Cultures were generated 
from six pups per experiment to ensure sufficient spinal 
cord slice cultures were available for all experimental 
groups; cultures were randomly allocated to experimen-
tal groups. Each experiment was repeated at least three 
times. Spinal cords were removed and a 5 mm segment 
of cervical-thoracic spinal cord dissected into spinal 
growth culture media (containing 50 % minimal essential 
medium, 25 % heat-inactivated horse serum, 25 % Earl’s 
balanced salt solution, supplemented with 1 % pen/strep, 
1 % glutamax, 0.5 % fungizone, 1.4 % d-glucose). Spinal 
cords were placed with the posterior surface uppermost 
and 200  μm (for rat) or 300  µm (for mouse) longitudi-
nal slices generated using a Mcllwain Tissue Chopper. 
Three slices were transferred to each Millicell-CM low 
height cell culture membrane (Millipore, Germany) and 
cultured in six-well plates; each well containing 1 ml spi-
nal growth culture media. The spinal slices were cultured 
for 7–17 days at 37 °C 5 % CO2, with fresh spinal media 
supplied every second day. The media change after 6 DIV 
incorporated 24.8 mM Hepes into the spinal cord media 
to buffer pH changes during light therapy. Note that 
myelinated axons were not observed in slice cultures pre-
pared from P3–4 day old rat pups at 4, 7, 10, 17 or 24DIV 
(not shown) and cultures from pups of this age were not 
examined further.
Transection of cultures and R/NIR light treatment
Phototherapy was administered to the organotypic spinal 
slices using custom-built LED arrays. The four individ-
ual narrow-band LED arrays delivered light with centre 
wavelengths of 449, 516, 662 and 865  nm (referred to 
hereafter as 450, 510, 660 and 860 nm, respectively). The 
emitted light intensity of each device was controlled by 
adjusting the current supplied to the LEDs and measured 
using a calibrated CCD spectroradiometer (USB 4000, 
Ocean Optics) fitted with a cosine collector, allowing 
calculation of the total number of photons delivered at 
all emitted wavelengths using the Spectrasuite software 
program (Ocean Optics). The light output of each LED 
device was adjusted to produce equal photon irradiance 
when delivered at a fixed distance of 5 cm above the spi-
nal slices, with the LED array fixed above the cultures to 
allow uniform illumination while not touching the cul-
ture dish. Light doses were delivered to cultures at three 
intensities [1.93 × 1016 (low), 3.85 × 1016 (intermediate) 
and 7.70 ×  1016 (high) photons/cm2/s] at each nominal 
wavelength. Sham-treated control spinal cord slices were 
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subject to identical treatment conditions, but the overly-
ing LED device was not switched on. Lower intensities 
were delivered prior to higher intensities to ensure resid-
ual heat was not a confounding factor in low intensity 
treatments. All cultures were also exposed to normal lab-
oratory lighting conditions during the treatment process; 
the culture incubator is a dark environment.
After 7 DIV a #11 scalpel blade was used to make a full 
depth cut partway through the width of the slice, at the 
midpoint of each slice, to induce a partial transection 
insult. Light treatment was applied to the membranes 
containing the slice cultures for a duration of 30 min, the 
first treatment delivered immediately following insult and 
the second 24 h following insult. Temperature was moni-
tored and maintained at 37  °C throughout treatment 
using an incubator, whilst pH was controlled by the prior 
addition of Hepes (24.76  mM) to the media. Immedi-
ately following the second 30-min light treatment, slices 
were fixed on the culture membranes for 30 min with 4 % 
paraformaldehyde in 0.1 M phosphate buffer and washed 
with phosphate buffered saline (PBS). Slices on mem-
brane were cut out and stored at 4  °C in a 24 well plate 
containing PBS azide (0.1 % sodium azide in sterile PBS, 
1 ml/well) for future immunohistochemical analyses.
Immunohistochemical analyses
Immunohistochemical analyses were conducted on spi-
nal slices still adhered to the membranes according to 
established procedures [48], using primary antibod-
ies recognizing: 3NT(1:500; Abcam, Cambridge, UK); 
β-III Tubulin (1:500; Covance); neurofilament (NFH) 
(1:50,000; Encor); 8OHDG (1:500; Abcam, Cambridge, 
UK); HNE (1:200; Jomar Bioscience); MnSOD (1:500, 
StressGen); MBP (1:500, Abcam); Olig2 (1:500; Abcam); 
NG2 (1:250; Invitrogen); IBA1 (1:500; Novachem), ED-1 
(1:500; Millipore) incubated overnight with the slices at 
4  °C. Secondary antibodies were species-specific Alex-
aFluor® 555- and 488-conjugated (1:400; Invitrogen), 
with the addition of Hoechst nuclear stain (1:1000; Invit-
rogen, VIC); incubated for 2 h at room temperature.
The specificity of the 3NT antibody was assessed using 
PC12 cells grown in RPMI medium supplemented with 
10 % horse serum, 5 % fetal bovine serum, 2 mM l-glu-
tamine, 2  mM penicillin–streptomycin, 1  mM MEM 
sodium pyruvate and 0.1 mM MEM non-essential amino 
acids (GIBCO ®, Invitrogen, Carlsbad, California, USA), 
on flasks coated with poly-l-lysine (PLL; 10  μg/ml; 
Sigma, St Louis, Missouri, USA) and housed in an incu-
bator at 37  °C, 5  % CO2. Cells were seeded at 4  ×  104 
cells/well of a PLL coated 24 well plate, allowed to adhere 
and then incubated with 1, 3 or 10  mM SIN-1 (Sigma-
Aldrich) for 24  h. 5  µl samples of resultant cell culture 
supernatants were assessed by dot-blot.
Microscopy and image analysis
For each experiment, intensity of immunoreactivity was 
visualized and imaged in a single session using a Nikon 
Eclipse Ti Inverted Microscope (Nikon Corporation, 
Japan) or a Leica SP7 confocal: images were captured at 
constant exposure settings across all treatment groups. 
Each experiment was repeated at least three times, using 
cultures prepared on different days. Images were cap-
tured at areas both close and distal to the injury site, 
with two close and two distal images taken per slice. 
Two spinal cord slices were imaged per treatment group, 
generating eight data points for each group. Each image 
consisted of a stack of 13 visual slices captured at 0.5 μm 
increments along the z-axis, and obtained from the mid-
dle 6  μm of the slice. Images captured using the non-
confocal microscope were deconvoluted using autoquant 
blind deconvolution with Nikon Elements AR software. 
Image analysis was conducted on a single central visual 
slice using ImageJ/Fiji analysis software, setting constant 
arbitrary threshold intensities for all images in an analysis 
and determining the area above the threshold intensity 
and the mean intensity of fluorescence of the image.
Statistical analysis
All data are displayed as mean ±  standard error of the 
mean (SEM). Statistical analyses were conducted using 
SPSS statistical software. Data from regions both close 
and distal to the transection were combined, as statis-
tical analysis using nonparametric Wilcoxon paired-
samples test revealed no significant differences between 
the regions (p ≤ 0.05). Equality of variance F-tests were 
conducted to test for homogeneity of variance in groups 
within experiments. Collated data were analysed by 
comparing treated to control using analysis of variance 
(ANOVA) with Games Howell post hoc test at 95  % 
confidence intervals (p  ≤  0.05). Statistical assessments 
were conducted independently for each experiment and 
representative analyses shown; it is not possible to aver-
age immunohistochemical intensity data from different 
experiments due to inter-experiment variability in base-
line values.
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